HOOKIPA Pharma
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of HOOKIPA Pharma generated cash of -$57,524,000, which is less than the previous year. Cash used in financing activities reached the amount of $65,670,000 last year. Net change in cash is therefore $4,077,000.
Cash Flow
| 2017 | -11.91M | -1.29M | 58.89M |
|---|---|---|---|
| 2018 | -14.99M | -2.15M | 6.87M |
| 2019 | -41.73M | -1.99M | 109.75M |
| 2020 | -39.33M | -2.37M | 73.42M |
| 2021 | -66.01M | -12.58M | -235K |
| 2022 | -19.99M | -5.01M | 72.27M |
| 2023 | -57.52M | -4.15M | 65.67M |
HOOK Cash Flow Statement (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
Cash at beginning of period | 113.44M | 66.91M | 143.17M | 113.57M | 48.58M | 61.36M | 13.18M |
Operating activities | |||||||
Net income | -81.58M | -64.91M | -75.66M | -44.08M | -43.03M | -16.23M | -12.72M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||
Depreciation and amortization | 3.55M | 3.60M | 4.64M | 4.15M | 1.44M | 640K | 398K |
Stock-based compensation expense | 2.34M | 5.04M | 7.64M | 8.65M | 5.56M | 0 | 770K |
| Deferred income tax benefit | 2.34M | 5.04M | 7.64M | 8.65M | 5.56M | 0 | 770K |
| Changes in operating assets and liabilities: | |||||||
Accounts receivable, net | 3.45M | -341K | -1.94M | -3.57M | -3.61M | -4.99M | 0 |
Inventories | 0 | 0 | -4.19M | -11.35M | -3.52M | -7.28M | 0 |
Accounts payable | 6.49M | -1.99M | 858K | 6.29M | 4.20M | 3.41M | -1.17M |
Cash generated by operating activities | -57.52M | -19.99M | -66.01M | -39.33M | -41.73M | -14.99M | -11.91M |
Investing activities | |||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -4.15M | -5.01M | -12.58M | -2.37M | -1.99M | -2.15M | -1.29M |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -4.15M | -5.01M | -12.58M | -2.37M | -1.99M | -2.15M | -1.29M |
Financing activities | |||||||
Common Stock Issued | 49.04M | 45.69M | 203K | 42.63M | 74.75M | 9K | 58.14M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -1.75M | -2.85M | -438K | -1.41M | -2.27M | 0 | 747K |
Cash used in financing activities | 65.67M | 72.27M | -235K | 73.42M | 109.75M | 6.87M | 58.89M |
Net Change In Cash | 4.07M | 46.53M | -76.26M | 29.60M | 64.99M | -12.78M | 48.17M |
Cash at end of period | 117.52M | 113.44M | 66.91M | 143.17M | 113.57M | 48.58M | 61.36M |
| Data source | Data source | Data source | Data source | Data source |